Natures Sunshine (NASDAQ: NATR) EVP reports new RSU grant and share vesting

Rhea-AI Filing Summary

Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported compensation-related share activity. He acquired 1,541 Common Shares on March 6, 2026 through the vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone of $48M over a rolling 12‑month period.

On the same date, 527 Common Shares were withheld at $25.06 per share to cover taxes due at vesting, a non-market disposition. He also received a grant of 10,088 restricted stock units, each representing one NATR share, vesting in three equal annual installments through March 6, 2029. Following these transactions, he directly holds 64,079 Common Shares, with additional equity exposure through the new RSU grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Norman Daniel C

(Last) (First) (Middle)

2901 WEST BLUEGRASS BLVD.

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATURES SUNSHINE PRODUCTS INC [ NATR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President, Asia

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/06/2026		M		1,541	A	$0(1)	64,606	D
Common Shares	03/06/2026		F		527	D	$25.06(2)	64,079	D
Common Shares	03/06/2026		A		10,088	A	$25.06(3)	74,167	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are vested shares resulting from the achievement of an adjusted EBITDA milestone of $48M over a rolling 12-month period pursuant to a March 11, 2024, performance-based restricted stock unit grant to the reporting person. As a result, half of the target vests upon achievement of the target and another half will vest one year following the achievement of such milestone.

2. Represents shares of NATR common stock withheld to pay taxes upon vesting of restricted stock units granted to the reporting person on March 6, 2026. The number of shares withheld was determined on March 6, 2026, based on the closing price of NATR common stock on that date.

3. These shares are in the form of restricted stock units (RSUs). Each RSU represents the right to receive one share of NATR common stock. These RSUs vest in three equal annual installments from the initial grant date through March 6, 2029.

Remarks:

	/s/ Nathan G. Brower as attorney-in-fact for Daniel C. Norman	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did NATR executive Daniel C. Norman report on March 6, 2026?

Daniel C. Norman reported vesting of 1,541 Common Shares from performance-based RSUs and a tax withholding of 527 shares on March 6, 2026. He also received a grant of 10,088 restricted stock units that vest over three years through March 6, 2029.

How many NATR shares does Daniel C. Norman hold after these Form 4 transactions?

After the reported transactions, Daniel C. Norman directly holds 64,079 Common Shares of Natures Sunshine Products. In addition, he was granted 10,088 restricted stock units, providing further potential share ownership as they vest in three equal annual installments through March 6, 2029.

What performance milestone triggered Daniel C. Norman’s vested NATR shares?

The vesting of 1,541 NATR shares resulted from achieving an adjusted EBITDA milestone of $48M over a rolling 12‑month period. This performance target was tied to a March 11, 2024 performance-based restricted stock unit grant awarded to Daniel C. Norman by the company.

Were Daniel C. Norman’s NATR share dispositions open-market sales?

No, the 527-share disposition reported by Daniel C. Norman was a tax-withholding event, not an open-market sale. Shares of NATR common stock were withheld to pay taxes due upon vesting of restricted stock units determined using the March 6, 2026 closing price.

What are the terms of the 10,088 restricted stock units granted to NATR’s Daniel C. Norman?

Daniel C. Norman received 10,088 restricted stock units, each representing one NATR common share. These RSUs vest in three equal annual installments from the initial grant date through March 6, 2029, subject to the standard vesting conditions described in the award documentation.

Does the NATR Form 4 show any remaining derivative positions for Daniel C. Norman?

The Form 4 derivative section shows no remaining derivative securities after these transactions. Equity exposure is reflected through 64,079 directly held Common Shares and 10,088 newly granted restricted stock units scheduled to vest annually through March 6, 2029, if vesting conditions are met.